To clarify the correlation between IDO1 or TDO2 expression and overall survival (OS) or progression-free survival (PFS) of CRC patients, IDO1 or TDO2 protein expression was evaluated by IHC in 192 paraffin-embedded CRC tissues. The gene discussed is IDO1; the disease is colorectal carcinoma.